Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 45 - Medicinal preparations containing active ingredients not provided for in groups
Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020)
12/1996
12/19/1996WO1996040133A1 Optically pure (-) norcisapride for treating digestive tract disorders
12/19/1996WO1996040132A1 Method for inhibiting neoplastic disease in mammals
12/19/1996WO1996040131A1 Method for inhibiting neoplastic disease in mammals
12/19/1996WO1996040128A2 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
12/19/1996WO1996040123A1 Antigen-processing cell-targeted conjugates
12/19/1996WO1996040108A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996WO1996040103A1 Treatment of a trabecular meshwork whose cells are subject ot inhibition of cell division with non-steroidal anti-inflammatory drugs
12/19/1996WO1996040102A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
12/19/1996WO1996040090A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
12/19/1996WO1996040056A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996WO1996040055A2 Biological agent compositions
12/19/1996WO1996040048A2 Novel uses for thyroid hormones or thyroid hormone-like compounds
12/19/1996WO1996040047A1 Alpha hydroxyacid esters for skin aging
12/19/1996WO1996040039A2 Isolated nucleic acid molecules, peptides which form complexes with mhc molecule hla-a2 and uses thereof
12/19/1996WO1996039996A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors
12/19/1996WO1996039869A1 Health food product
12/19/1996WO1996031237A3 Cancer treatment by photodynamic therapy, in combination with an immunoadjuvant
12/19/1996WO1996029973A3 Compositions and methods for inhibiting thrombogenesis
12/19/1996CA2236946A1 Polyether block copolymer micellar compositions for targeting biological agents
12/19/1996CA2224222A1 Spironolactone and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996CA2224115A1 Multidentate metal complexes and methods of making and using thereof
12/19/1996CA2224079A1 Epoxy-steroidal aldosterone antagonist and angiotensin ii antagonist combination therapy for treatment of congestive heart failure
12/19/1996CA2224005A1 Optically pure (-) norcisapride for treating digestive tract disorders
12/19/1996CA2223948A1 Chalcone retinoids and methods of use of same
12/19/1996CA2223891A1 Treatment of insulin resistance
12/19/1996CA2223889A1 Supplemented and unsupplemented tissue sealants, methods of their production and use
12/19/1996CA2223885A1 Platelet-specific chimeric immunoglobulin and methods of use therefor
12/19/1996CA2223878A1 Inhibitors of phospholipase a2
12/19/1996CA2223640A1 Methods of reducing toxicity of chemotherapeutic and antiviral agents with acylated pyrimidine nucleosides
12/19/1996CA2223611A1 Appetite regulating compositions
12/19/1996CA2223590A1 Method for reducing or preventing post-surgical adhesion formation using 5-lipoxygenase inhibitors
12/19/1996CA2223581A1 Use of debromohymenialdisine and related compounds for treating osteoarthritis
12/19/1996CA2223499A1 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
12/19/1996CA2223327A1 Augmented atp production
12/19/1996CA2223324A1 Alpha hydroxyacid esters for skin aging
12/19/1996CA2223303A1 Treatment of t cell mediated autoimmune disorders
12/19/1996CA2223179A1 Phosphonic acid-based cationic lipids
12/19/1996CA2222941A1 A cytotoxicity-based genetic selection system (toxsel)
12/19/1996CA2222930A1 Treatment of a trabecular meshwork whose cells are subject to inhibition of cell division with non-steroidal anti-inflammatory drugs
12/19/1996CA2222929A1 Non-steroidal anti-inflammatory drugs for the cyto-protection of the trabecular meshwork
12/19/1996CA2222776A1 Biological agent compositions
12/19/1996CA2222625A1 Treatment and prevention of prostatic disease
12/19/1996CA2222231A1 Antibody and antibody fragments for inhibiting the growth of tumors
12/19/1996CA2221986A1 Method for identifying alzheimer's disease therapeutics using transgenic animal models
12/19/1996CA2219981A1 Method for regulating metabolism with dopamine beta hydroxylase inhibitors
12/19/1996CA2219980A1 Method for inhibiting neoplastic disease in mammals
12/19/1996CA2218541A1 Novel targeted compositions for diagnostic and therapeutic use
12/18/1996EP0748627A2 Melatonin agonists for use in the treatment of benign prostatic hyperplasia
12/18/1996EP0748222A1 Antitussive composition containing an antitussive and benzydamine
12/17/1996US5585355 Drug delivery with a bradykinin derivatives
12/17/1996US5585347 Measuring prolactin level in blood at spaced intervals during subjects waking and sleeping periods over twenty four hours to create a profile; comparing to control
12/17/1996CA2059526C Partial agonists of the strychnine insensitive glycine modulatory site of the n-methyl-d-asparate receptor complex as neuropsychopharmacological agents
12/12/1996WO1996039541A1 Colon specific gene and protein
12/12/1996WO1996039540A1 Novel gene-up regulated in regenerating liver
12/12/1996WO1996039522A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996WO1996039509A1 Fibroblast growth factor 15
12/12/1996WO1996039497A1 Transforming growth factor alpha hi
12/12/1996WO1996039485A1 Human hepatoma-derived growth factor-2
12/12/1996WO1996039442A1 G-protein receptor htnad29
12/12/1996WO1996039439A1 Human g-protein receptor hcegh45
12/12/1996WO1996039437A1 Human g-protein chemokine receptor hdgnr10
12/12/1996WO1996039434A1 Human g-protein receptor hgber32
12/12/1996WO1996039420A1 Human criptin growth factor
12/12/1996WO1996039185A1 Treatment and diagnosis of prostate cancer
12/12/1996WO1996039184A1 THERAPEUTIC SEPSIS TREATMENT USING ANTAGONISTS TO PTHrP
12/12/1996WO1996039171A1 Therapy using lymphotoxin and thrombopoietin
12/12/1996WO1996039164A1 Use of angiotensin ii type 2 receptor agonists in tissue repair
12/12/1996WO1996039156A2 Phosphate-binding polymers for oral administration
12/12/1996WO1996039142A1 Pharmaceutical composition comprising a proteinase inhibitor and a monoglyceride
12/12/1996WO1996039140A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS
12/12/1996WO1996039134A1 Osteogenetic promoting pharmaceutical composition
12/12/1996WO1996039053A2 Mineral supplements for dietetic food
12/12/1996WO1996039033A1 Betulinic acid derivatives and uses therefor
12/12/1996WO1996033730A3 Chemokine binding protein and methods of use therefor
12/12/1996CA2223957A1 Transforming growth factor alpha hi
12/12/1996CA2223733A1 Human hepatoma-derived growth factor-2
12/12/1996CA2223707A1 Novel gene-up regulated in regenerating liver
12/12/1996CA2223291A1 Treatment and diagnosis of prostate cancer
12/12/1996CA2222280A1 Human chemokine beta-11 and human chemokine alpha-1
12/12/1996CA2221842A1 Alpha 1a adrenergic receptor antagonists
12/12/1996CA2221795A1 Colon specific gene and protein
12/12/1996CA2221784A1 Osteogenetic promoting pharmaceutical composition
12/12/1996CA2221706A1 G-protein receptor htnad29
12/12/1996CA2221637A1 Human g-protein receptor hcegh45
12/12/1996CA2221274A1 Human g-protein receptor hgber32
12/12/1996CA2220336A1 Therapy using lymphotoxin and thrombopoietin
12/12/1996CA2217301A1 Fibroblast growth factor 15
12/11/1996EP0747049A1 Use of tachykinin antagonists in combination with serotonin agonists or serotonin reuptake inhibitors for the manufacture of a medicament for the treatment of allergic rhinitis
12/11/1996EP0747047A1 Combination of an antimicrobial compound (e.g. the lipoaminoacid N,n-octanoyl-glycine) and a monoalkylglycerol ether and its use as an antimicrobial agent
12/11/1996EP0747033A1 Transfusion liquid-containing holder and prepared transfusion liquid
12/11/1996EP0746567A1 Novel opioid peptides for the treatment of pain and use thereof
12/11/1996EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof
12/11/1996EP0746324A1 Method of combatting osteoporosis and other disease states in mammalian subjects, utilizing organic boron compounds
12/11/1996EP0532512B1 Use of platelet activating factor antagonists as anti-pruritic agents
12/11/1996EP0521080B1 Synergistic compositions
12/11/1996CN1137826A Method and compositions for treatment of BCR-ABL associated leukemias and other cell proliferative disorders
12/11/1996CN1137758A Methods of prolonged suppression of humoral immunity
12/11/1996CN1137755A 6-(2-imidazolinylamino) quinoxaling compounds useful as alpha-2 adrenoceptor agonists
12/10/1996US5583233 Retroviral protease inhibiting compounds
12/10/1996US5583232 Treating human immunodeficiency virus infections
1 ... 1083 1084 1085 1086 1087 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 ... 1151